Back to search resultsSummaryRMgm-1157
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene mutation, Gene mutation |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 25565321 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Ganter M, Matuschewski K |
Name Group/Department | Parasitology Unit |
Name Institute | F-actin-capping protein subunit alpha, putative |
City | Berlin |
Country | Germany |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-1157 |
Principal name | cpα(-)::PfCPα X cpβ(-)::PfCPβ |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Not different from wild type |
Oocyst | Reduced numbers of oocysts. Oocysts produce midgut sporozoites. |
Sporozoite | Reduced numbers of oocysts. Oocysts produce midgut sporozoites. Small numbers of sporozoites inside salivary glands that are infective to mice. |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Protein (function) See the link F-actin-capping protein subunits for other mutants with mutated F-actin-capping protein subunits Phenotype analyses of with the single gene cpβ replacement mutant RMgm-1156 show strongly reduced numbers of oocysts in A. stephensi mosquitoes and absence of salivary gland sporozites. The double replacement P. berghei mutant in which both the cpα and cpβ genes are replaced with the complete P. falciparum cpα and cpβ genes (RMgm-1157) shows a partial rescue of the phenotype with low numbers of sporozoites present in salivary glands. Combined these observations indicate that i) trans-species complementation of both subunits is needed to rescue the severe sporozoite defect as seen in both single replacement mutants and that ii) a functional CP heterodimer is necessary for normal oocyst and sporozoite development. Other mutants |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1243100 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0528500 | ||||||||||||||||||||||||||
Gene product | F-actin-capping protein subunit alpha, putative | ||||||||||||||||||||||||||
Gene product: Alternative name | CPalpha, CPα | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Short description of the mutation | P. berghei cpα replacement with the complete P. falciparum cpα gene | ||||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||||
Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | In the mutant the P. berghei cpα and cpβ gene is replaced with the complete P. falciparum cpα and cpβ orthologs. The P. falciparum genes are under the control of the P. berghei cpα and cpβ promoter region, respectively. The mutant has been generated by crossing the single gene cpα replacement mutant RMgm-1154 with the single gene cpβ replacement mutant RMgm-1156. For targeted disruption of PbCPα, two fragments were amplified from P. berghei genomic DNA as template using primers PbCPα_forI and PbCPα_revII to amplify the 5’ flanking region, and PbCPα_forIII and PbCPα_revIV for amplification of the 3’ flanking region. Cloning into the P. berghei transfection plasmid b3D.DT^H.^D resulted in the plasmid pPbCPαrep. In order to complement cpα(-) parasites, we amplified the orthologous P. falciparum CPα gene using the primers PfCPα_compforV and PfCPα_comprevVI and P. falciparum cDNA as template. Cloning into the plasmid pPbCPαrep resulted in the complementation plasmid pPfCPα. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1232400 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0517600 | ||||||||||||||||||||||||||
Gene product | F-actin-capping protein subunit beta, putative | ||||||||||||||||||||||||||
Gene product: Alternative name | CPbeta, CPβ, UIS17, upregulated in infectious sporozoites gene 17 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Short description of the mutation | P. berghei cpα and cpβ gene replacement with the P. falciparum cpα and cpβ orthologs | ||||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||||
Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | In the mutant the P. berghei cpα and cpβ gene is replaced with the complete P. falciparum cpα and cpβ orthologs. The P. falciparum genes are under the control of the P. berghei cpα and cpβ promoter region, respectively. The mutant has been generated by crossing the single gene cpα replacement mutant RMgm-1154 with the single gene cpβ replacement mutant RMgm-1156. To complement cpβ(-) parasites, we amplified the orthologous P. falciparum CPβ gene using the primers PfCPβ_compforV and PfCPβ_comprevVI and P. falciparum genomic DNA as template. Cloning into the plasmid pPbCPβREP (Ganter et al., 2009) resulted in the plasmid pPfCPβ with PfCPβ under the control of the endogenous PbCPβ promoter and the 3’ untranslated region of PbDHFR/TS. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |